Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Strictly Stocks is a financial media and investment research platform that provides news, analysis, and data on the global stock markets, with a significant focus on the biotechnology and life sciences sectors. The company specializes in delivering real-time market updates, technical analysis, and stock picks to a community of retail and professional investors interested in high-volatility sectors. While it provides extensive commentary on clinical trial results and regulatory milestones, Strictly Stocks is not a healthcare or biotech company itself and does not conduct its own research and development. Its primary offerings include digital content, newsletters, and social media-based financial insights tailored to the 'BioTwitter' and retail trading communities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on StrictlyStocks.